| NCT ID | NCT06818370 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 86 participants |
| Start Date | 2025-02-03 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 86 participants in total. It began in 2025-02-03 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.
Eligibility Criteria
Inclusion Criteria: * • To have been diagnosed with breast cancer. * The chemotherapy treatment plan should be planned as the Doxorubicin-Cyclophosphamide protocol. * Volunteer to participate in the study. * Be 18 years of age or older. * Being a woman. Exclusion Criteria: * • Having any health problem or disability that prevents communication (vision-hearing problems, neurological, psychiatric diseases). * Planning other treatments other than the Doxorubicin-Cyclophosphamide protocol for the treatment of breast cancer. * Not volunteering to participate in the study. * Having previously experienced any disease/skin problem that causes hair loss. * Having received chemotherapy before.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06818370 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06818370 currently recruiting?
Yes, NCT06818370 is actively recruiting participants. Contact the research team at dakdevirismail@gmail.com for enrollment information.
Where is the NCT06818370 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06818370 clinical trial?
NCT06818370 is sponsored by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. The trial plans to enroll 86 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.